StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Whatever you do

<< Previous

Bullboard Posts

Next >>

Comment by johnny007on Jun 03, 2021 10:35am

116 Views

Post# 33318563

RE:RE:RE:Whatever you do

Aristotle is now valued as if not existent. Good for us here.

Aristotle rollout plan is delayed by roughly 6 month only, compared to Clarus earlier plan and unlike Clarus new negativity of 2 years. Good for us here.

Let's celebrate the upcoming Aristotle paper and SHIFT product advertisements.

C$32M MCAP is 1/10 of what still super cheap stocks in this sector are traded for ;-)

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?